Overview

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe when added to treatment with lithium or Divalproex for the treatment of patients with bipolar I depression.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Lithium Carbonate
Lurasidone Hydrochloride
Valproic Acid